Synapse

← Deepak L. Bhatt

Papers by Deepak L. Bhatt

Page 2 · newest first

  1. Refining the Role of Beta-Blockers in Cardiovascular MedicineJournal of the American College of Cardiology · 2026
  2. Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial InfarctionJournal of the American College of Cardiology · 2017
  3. Lipoprotein (a) Variability in High Cardiovascular Risk Individuals with Hypertriglyceridemia and Controlled LDL-C on Statin Therapy in REDUCE-ITJournal of clinical lipidology · 2026
  4. Outcomes of Surgical Versus Transcatheter Mitral Valve Repair or Replacement in Patients With Myocardial Infarction and Concomitant Mitral Regurgitation: A Retrospective Analysis of Real-World DataJournal of the Society for Cardiovascular Angiography & Interventions · 2026
  5. Psychosocial Stress–Induced Takotsubo Syndrome in a Male PatientJACC Case Reports · 2026
  6. Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysisEuropean Heart Journal · 2026
  7. Incidence of Dementia in Older Adults Hospitalized With Acute Coronary SyndromeJACC Advances · 2026
  8. Cardiovascular Mortality After Type 1 and Type 2 Myocardial Infarction in Young AdultsJournal of the American College of Cardiology · 2020
  9. Serial high-sensitivity troponin-T and risk of heart failure in individuals with suspected acute coronary syndromeInternational Journal of Cardiology · 2026
  10. Benefit of Sotagliflozin Across the Full Range of Baseline Blood Pressure in the SOLOIST-WHF TrialJACC Heart Failure · 2026
  11. Aspirin for Primary Prevention of Cardiovascular EventsJournal of the American College of Cardiology · 2019
  12. Cluster-Randomized Trials — Insights from Cardiovascular PreventionNEJM Evidence · 2026
  13. Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and BleedingJournal of the American College of Cardiology · 2013
  14. Rates of Lipoprotein(a) Oxidation Accelerate at Elevated Levels and Attenuate With Atorvastatin Active Metabolites Compared With Other StatinsJACC Basic to Translational Science · 2026
  15. Clinical Trials in Peripheral Vascular DiseaseCirculation · 2014
  16. Use of Guideline-Recommended Risk Reduction Strategies Among Patients With Diabetes and Atherosclerotic Cardiovascular DiseaseCirculation · 2019
  17. Effect of Evolocumab on Grafts Post-Coronary Artery Bypass SurgeryJACC Advances · 2026
  18. Evaluating percutaneous support for cardiogenic shock: data shock and sticker shockEuropean Heart Journal · 2009
  19. Abciximab reduces mortality in diabetics following percutaneous coronary interventionJournal of the American College of Cardiology · 2000
  20. Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesEuropean Heart Journal · 2009
  21. Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary InterventionJournal of the American College of Cardiology · 2017
  22. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trialEuropean Heart Journal · 2020
  23. Variations in Coronary Artery Disease Secondary Prevention Prescriptions Among Outpatient Cardiology PracticesJournal of the American College of Cardiology · 2013
  24. Causes and Risk Factors for Death in DiabetesJournal of the American College of Cardiology · 2021
  25. Coronary CTA in the Evaluation of Stable Chest PainJournal of the American College of Cardiology · 2017
  26. Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following AngiographyJournal of the American College of Cardiology · 2020
  27. Cellular basis of HFpEF: contributions of abnormal lipidsFrontiers in Cardiovascular Medicine · 2026
  28. Trends and Outcomes of Antithrombotic Strategies for Valve-in-Valve TAVRJACC: Cardiovascular Interventions · 2026
  29. Lipoprotein(a), smoking, and diabetes are additive but not interactive risk factors for major adverse cardiovascular events after acute coronary syndromeAmerican Journal of Preventive Cardiology · 2026
  30. Causes, Angiographic Characteristics, and Management of Premature Myocardial InfarctionJournal of the American College of Cardiology · 2022
  31. Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration LabelingJournal of the American College of Cardiology · 2018
  32. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19Journal of the American College of Cardiology · 2023
  33. Cocaine and Marijuana Use Among Young Adults With Myocardial InfarctionJournal of the American College of Cardiology · 2018
  34. Metabolic SurgeryJournal of the American College of Cardiology · 2018
  35. Pathology of Peripheral Artery Disease in Patients With Critical Limb IschemiaJournal of the American College of Cardiology · 2018
  36. Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trialEuropean Heart Journal · 2024
  37. Optimal medical therapy for initial management of stable angina: a call to actionEuropean Heart Journal · 2025
  38. Primary Prevention of Subclinical Atherosclerosis in Young AdultsJournal of the American College of Cardiology · 2023
  39. Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart FailureJournal of the American College of Cardiology · 2020
  40. Baseline anaemia and short dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary interventionEuropean Journal of Preventive Cardiology · 2026
  41. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 weekEuropean Heart Journal · 2022
  42. Profound reductions in first and total cardiovascular events with icosapent ethyl in the REDUCE-IT trial: why these results usher in a new era in dyslipidaemia therapeuticsEuropean Heart Journal · 2019
  43. Peripheral artery disease: advances in medical therapyEuropean Heart Journal · 2026
  44. Comparison of ASCVD Risk Prediction Models in STEMIJACC Asia · 2026
  45. The National Cardiovascular Data Registry Data Quality Program 2020Journal of the American College of Cardiology · 2022
  46. Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR ScoreJACC: Cardiovascular Interventions · 2026
  47. Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese PatientsJournal of the American College of Cardiology · 2018
  48. Temporal Trends and Factors Associated With Cardiac Rehabilitation Referral Among Patients Hospitalized With Heart FailureJournal of the American College of Cardiology · 2015
  49. Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart FailureJournal of the American College of Cardiology · 2021
  50. Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary DiseaseJournal of the American College of Cardiology · 2018